Showing 141 - 160 results of 743 for search '"chronic kidney disease"', query time: 0.11s Refine Results
  1. 141
  2. 142

    PROFILE OF INCOMPATIBLE REACTIONS TO PACKED RED CELL TRANSFUSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT SANGLAH HOSPITAL by I Nyoman Arsana, Ni Nyoman Sri Puspa Adi, Ni Ketut Ayu Juliasih

    Published 2023-07-01
    “…Purpose: To assess the profile of incompatible reactions in PRC transfusions of chronic kidney disease patients at Sanglah Hospital, Denpasar. …”
    Get full text
    Article
  3. 143
  4. 144
  5. 145
  6. 146

    Creatinine- and Cystatin C-Based Incidence of Chronic Kidney Disease and Acute Kidney Disease in AKI Survivors by Claire Rimes-Stigare, Bo Ravn, Akil Awad, Klara Torlén, Claes-Roland Martling, Matteo Bottai, Johan Mårtensson, Max Bell

    Published 2018-01-01
    “…Acute kidney disease (AKD) describes renal dysfunction 7 to 90 days after AKI and is determined by percentage change in creatinine from baseline. Chronic kidney disease (CKD) is defined as the estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73 m2 persisting for more than 90 days. …”
    Get full text
    Article
  7. 147

    Association of composite dietary antioxidant index with mortality risk among adults with chronic kidney disease in NHANES by Jun Sun, Haoyu Yang, Aru Sun, Huifang Guan, Weinan Xie, Lin Han, Yu Wei, Xiaoyu Zang, Pengfei Xie, Xiaolin Tong, Yiqun Lin

    Published 2025-01-01
    “…Abstract At present, the relationship between the intake of antioxidants in food and the mortality rate of patients with chronic kidney disease (CKD), especially the association with the mortality rate of specific causes, is not clear. …”
    Get full text
    Article
  8. 148

    Health-related quality of life in hypertensive patients with chronic kidney disease in low and middle-income countries by Wening Wulandari, Neily Zakiyah, Cherry Rahayu, Irma M. Puspitasari, Auliya A. Suwantika

    Published 2025-01-01
    “…Abstract Hypertension and chronic kidney disease (CKD) are interconnected conditions that can significantly affect a person’s health-related quality of life (HRQoL). …”
    Get full text
    Article
  9. 149

    Evaluation of the histopathological spectrum of skin biopsies in patients with chronic kidney disease: A single-center experience by Amany A Fathaddin

    Published 2024-04-01
    “…Background and Aim: Patients with chronic kidney disease (CKD), particularly those with end-stage renal disease (ESRD), frequently experience skin problems. …”
    Get full text
    Article
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154

    International Burden of Chronic Kidney Disease and Secondary Hyperparathyroidism: A Systematic Review of the Literature and Available Data by Elizabeth Hedgeman, Loren Lipworth, Kimberly Lowe, Rajiv Saran, Thy Do, Jon Fryzek

    Published 2015-01-01
    “…The international burden of secondary hyperparathyroidism (SHPT) is unknown, but it may be estimable through the available chronic kidney disease and SHPT literature. Structured reviews of biomedical literature and online data systems were performed for selected countries to ascertain recent estimates of the incidence, prevalence, and survival of individuals with CKD and SHPT. …”
    Get full text
    Article
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160

    Area deprivation index predicts annual chronic kidney disease screening and chronic kidney disease development among patients with newly diagnosed hypertension and type 2 diabetes in a large midwestern health system: a retrospective cohort study by Rasha Khatib, Todd Williamson, Rakesh Singh, Mary Ingle, Yuxian Du, Vesta Valuckaite, Sheldon Kong, Sarang Baman

    Published 2024-04-01
    “…Background We explore how area deprivation index (ADI), a national ranking of neighbourhood sociodemographic disadvantage is associated with chronic kidney disease (CKD) screening and development among patients with newly diagnosed hypertension (HTN) or type 2 diabetes (T2DM).Methods Patients (n=235 208) with a new HTN or T2DM diagnosis between 2015 and 2018 in a large healthcare system were followed for 3 years to evaluate CKD screening (one estimated glomerular filtration rate and urinary albumin-to-creatine ratio) and CKD development. …”
    Get full text
    Article